These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16889455)

  • 1. Risperidone-induced hyperprolactinemia in adolescents: A case series.
    Madhusoodanan S; Moise D
    J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
    Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
    Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cabergoline treatment of risperidone-induced hyperprolactinemia: a pilot study.
    Cavallaro R; Cocchi F; Angelone SM; Lattuada E; Smeraldi E
    J Clin Psychiatry; 2004 Feb; 65(2):187-90. PubMed ID: 15003071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone added to clozapine: impact on serum prolactin levels.
    Henderson DC; Goff DC; Connolly CE; Borba CP; Hayden D
    J Clin Psychiatry; 2001 Aug; 62(8):605-8. PubMed ID: 11561931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients.
    Melkersson K
    J Clin Psychiatry; 2005 Jun; 66(6):761-7. PubMed ID: 15960571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
    Fric M; Laux G
    Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone.
    Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA
    J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Prolactin levels and adverse events in patients treated with risperidone.
    Denisov MF
    J Clin Psychopharmacol; 2002 Oct; 22(5):538-40; author reply 540-1. PubMed ID: 12352286
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperprolactinaemia - a risperidone side-effect.
    Grahovac T; Ruzić K; Medved P; Pavesić-Radonja A; Dadić-Hero E
    Psychiatr Danub; 2010 Mar; 22(1):120-2. PubMed ID: 20305606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
    Montalvo I; Ortega L; López X; Solé M; Monseny R; Franch J; Vilella E; Labad J
    Int Clin Psychopharmacol; 2013 Jan; 28(1):46-9. PubMed ID: 23232756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels.
    Ahl J; Kinon BJ; Liu-Seifert H
    Ann N Y Acad Sci; 2004 Dec; 1032():289-90. PubMed ID: 15677431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
    Kinon BJ; Gilmore JA; Liu H; Halbreich UM
    Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():69-82. PubMed ID: 12650682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.